Surrey, Canada

Stefan R Idzan

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Shire International Licensing B.v.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stefan R Idzan. Retrieved from https://idiyas.com/inventor/stefan-r-idzan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Stefan R Idzan in Kidney Stone Disease Prevention

Introduction

Stefan R Idzan is an accomplished inventor based in Surrey, Canada. He has made significant contributions to the field of medical science, particularly in the prevention of kidney stone disease. His innovative approach utilizes rare earth compounds to address this common health issue.

Latest Patents

Stefan holds a patent for the "Use of rare earth compounds for the prevention of kidney stone disease." This patent addresses conditions such as kidney stones, which are characterized by undesired absorption of oxalate from the intestinal tract. His invention proposes the use of nontoxic salts of rare earth metal ions as a convenient treatment option.

Career Highlights

Stefan is associated with Shire International Licensing B.V., where he continues to work on innovative solutions in the medical field. His dedication to research and development has led to advancements that can potentially improve patient outcomes.

Collaborations

Stefan has collaborated with notable professionals in his field, including Michael J Abrams and Gary James Bridger. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Stefan R Idzan's work in the prevention of kidney stone disease through the use of rare earth compounds showcases his commitment to advancing medical science. His contributions are paving the way for new treatment options that can benefit many individuals suffering from this condition.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…